Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 26:9:1004036.
doi: 10.3389/fmolb.2022.1004036. eCollection 2022.

Cytoplasmic tail determines the membrane trafficking and localization of SARS-CoV-2 spike protein

Affiliations
Review

Cytoplasmic tail determines the membrane trafficking and localization of SARS-CoV-2 spike protein

Qinlin Li et al. Front Mol Biosci. .

Abstract

The spike (S) glycoprotein of SARS-CoV-2 mediates viral entry through associating with ACE2 on host cells. Intracellular trafficking and palmitoylation of S protein are required for its function. The short cytoplasmic tail of S protein plays a key role in the intracellular trafficking, which contains the binding site for the host trafficking proteins such as COPI, COPII and SNX27. This cytoplasmic tail also contains the palmitoylation sites of S protein. Protein palmitoylation modification of S protein could be catalyzed by a family of zinc finger DHHC domain-containing protein palmitoyltransferases (ZDHHCs). The intracellular trafficking and membrane location facilitate surface expression of S protein and assembly of progeny virions. In this review, we summarize the function of S protein cytoplasmic tail in transportation and localization. S protein relies on intracellular trafficking pathways and palmitoylation modification to facilitate the life cycle of SARS-CoV-2, meanwhile it could interfere with the host transport pathways. The interplay between S protein and intracellular trafficking proteins could partially explain the acute symptoms or Long-COVID complications in multiple organs of COVID-19 patients.

Keywords: COPI; SARS-CoV-2; SNX27; palmitoylation; spike.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Key sequences in cytoplasmic tail of SARS-CoV-2 S protein for palmitoylation and association with transport proteins. “MTSC” binds to PDZ domain of SNX27. “DEDDSE” associates with Sec24 subunit of COPII. “KLHYT” interacts with WD40 domain of αCOP and β′COP.
FIGURE 2
FIGURE 2
Intracellular trafficking of SARS-CoV-2 S protein mediated by COPI, COPII and SNX27.

References

    1. Cattin-Ortolá J., Welch L. G., Maslen S. L., Papa G., James L. C., Munro S. (2021). Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation. Nat. Commun. 12 (1), 5333. 10.1038/s41467-021-25589-1 - DOI - PMC - PubMed
    1. Chandra M., Kendall A. K., Jackson L. P. (2021). Toward understanding the molecular role of SNX27/retromer in human Health and disease. Front. Cell Dev. Biol. 9, 642378. 10.3389/fcell.2021.642378 - DOI - PMC - PubMed
    1. da Rosa Mesquita R., Francelino Silva Junior L. C., Santos Santana F. M., Farias de Oliveira T., Campos Alcântara R., Monteiro Arnozo G., et al. (2021). Clinical manifestations of COVID-19 in the general population: systematic review. Wien. Klin. Wochenschr. 133 (7-8), 377–382. 10.1007/s00508-020-01760-4 - DOI - PMC - PubMed
    1. Daniloski Z., Jordan T. X., Wessels H. H., Hoagland D. A., Kasela S., Legut M., et al. (2021). Identification of required host factors for SARS-CoV-2 infection in human cells. Cell 184 (1), 92–105. 10.1016/j.cell.2020.10.030 - DOI - PMC - PubMed
    1. Dey D., Singh S., Khan S., Martin M., Schnicker N. J., Gakhar L., et al. (2022). An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking. Commun. Biol. 5 (1), 115. 10.1038/s42003-022-03063-y - DOI - PMC - PubMed